26.09.2022 • News

Celanese Makes Concessions on DuPont Acquisition

Celanese has offered concessions to EU regulators to allay concerns about its proposed $11 billion acquisition of DuPont’s Mobility and Materials business, according to Reuters.

The US chemicals company filed its proposed remedies with the European Commission on Sep. 20 — the filing did not disclose the details. The Commission is seeking feedback from rival producers and customers before deciding by Oct. 11 whether to accept Celanese’s proposals, or make further demands.

If the Commission has serious concerns about the deal, it might open an investigation that could take four months to complete.

Photo

The transaction – announced in February and originally expected to close around the end of this year – would be DuPont’s biggest since splitting from DowDuPont in June 2019. DuPont is reshaping its portfolio as a “premier multi-industrial company” serving the automotive, consumer and industrial markets.

Author: Elaine Burridge, Freelance Journalist

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.